Trial · NCT00826241
Adverse events256
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 256
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Albumin, serum-low (hypoalbuminemia) | Metabolism and nutrition disorders | Temozolomide + Lapatinib | 6 | 50 | 20 |
| other | Alkaline phosphatase | Investigations | Temozolomide + Lapatinib | 7 | 50 | 18 |
| other | Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip) | Respiratory, thoracic and mediastinal disorders | Temozolomide + Lapatinib | 3 | 50 | 6 |
| other | Allergy/Immunology - Other (Specify, environmental allergic dry cough) | Immune system disorders | Temozolomide + Lapatinib | 1 | 50 | 2 |
| other | ALT, SGPT (serum glutamic pyruvic transaminase) | Investigations | Temozolomide + Lapatinib | 17 | 50 | 54 |
| other | Amylase | Investigations | Temozolomide + Lapatinib | 1 | 50 | 2 |
| other | Anorexia | Metabolism and nutrition disorders | Temozolomide + Lapatinib | 10 | 50 | 22 |
| other | AST, SGOT(serum glutamic oxaloacetic transaminase) | Investigations | Temozolomide + Lapatinib | 16 | 50 | 50 |
| other | Ataxia (incoordination) | Nervous system disorders | Temozolomide + Lapatinib | 6 | 50 | 14 |
| other | Auditory/Ear - Other (Specify, fluttering sensation) | Ear and labyrinth disorders | Temozolomide + Lapatinib | 1 | 50 | 2 |
| other | Auditory/Ear - Other (Specify, hearing loss; present at baseline) | Ear and labyrinth disorders | Temozolomide + Lapatinib | 1 | 50 | 2 |
| other | Bicarbonate, serum-low | Investigations | Temozolomide + Lapatinib | 1 | 50 | 2 |
| other | Bilirubin (hyperbilirubinemia) | Investigations | Temozolomide + Lapatinib | 4 | 50 | 16 |
| other | Blood/Bone Marrow - Other (Specify, BUN) | Blood and lymphatic system disorders | Temozolomide + Lapatinib | 1 | 50 | 2 |
| other | Blood/Bone Marrow - Other (Specify,elevated bilirubin) | Blood and lymphatic system disorders | Temozolomide + Lapatinib | 1 | 50 | 2 |
| other | Bronchospasm, wheezing | Respiratory, thoracic and mediastinal disorders | Temozolomide + Lapatinib | 3 | 50 | 6 |
| other | Bruising (in absence of Grade 3 or 4 thrombocytopenia) | Injury, poisoning and procedural complications | Temozolomide + Lapatinib | 2 | 50 | 4 |
| other | Calcium, serum-low (hypocalcemia) | Metabolism and nutrition disorders | Temozolomide + Lapatinib | 7 | 50 | 20 |
| other | Cardiac General - Other (Specify, sinus tachycardia) | Cardiac disorders | Temozolomide + Lapatinib | 1 | 50 | 2 |
| other | Cataract | Eye disorders | Temozolomide + Lapatinib | 1 | 50 | 2 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00826241/events